Labiotech.eu

News and Trends 20 Aug 2020

Is Hepatitis D Healthcare Being Overlooked?

Despite the recent EU approval of the first hepatitis D treatment, low public awareness remains an obstacle to tackling this aggressive infection. Earlier this month, the peptide drug Hepcludex became the first drug greenlit for hepatitis D treatment in Europe. This was a conditional market authorization granted to the German company MYR Pharmaceuticals based on […]

August 20, 2020 - 4 minutesmins - By Jonathan Smith

Best in Biotech 19 Aug 2020

7 Biotech Books to Read in the Sun this Summer

Here are seven biotech books for the summer that will take you from CRISPR gene editing to the microbiome to pharma and economics, as well as sci-fi that takes biotech to space. The excitement of the summer break has been dampened somewhat by the ever-present threat of the Covid-19 pandemic. No matter where you end […]

August 19, 2020 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Aug 2020

Women’s Health Gains Traction as Bayer Pays €736M for UK Firm

Bayer’s recent €736M ($875M) acquisition of KaNDy Therapeutics could herald growing investor interest in women’s health – a historically neglected field in the biotech and pharma industry. Through this deal, Bayer has snapped up KaNDy Therapeutics’ first-in-class drug for treating hot flashes and night sweats, which often occur during the menopause. In a phase IIb […]

August 18, 2020 - 3 minutesmins - By Jonathan Smith

cancer vaccine virus ervaxx cell therapy

News and Trends 17 Aug 2020

CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO

The share price of CureVac has skyrocketed almost fivefold after the Covid-19 vaccine developer priced a Nasdaq IPO at €180M ($213M). The excitement around messenger RNA (mRNA) vaccines against Covid-19 could also benefit other players in mRNA therapeutics. CureVac’s IPO was priced at €14 ($16) per share, giving the German company a valuation of around […]

August 17, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Aug 2020

Record Funding for Gene and Cell Therapy Accompanies Turbulent Times

European companies developing advanced therapies such as gene and cell therapies secured at least €2.2B ($2.6B) in the first half of 2020. While this is encouraging in the face of Covid-19, it hasn’t been smooth sailing for all startups in the field, with many struggling to stay afloat during crippling national lockdowns. The funding received […]

August 14, 2020 - 5 minutesmins - By Victor Kotsev

News and Trends 13 Aug 2020

Why are Some European Biotechs Going Public Without an IPO?

European biotech companies are flocking to the Nasdaq Stock Market in 2020, but not all are going the traditional Initial Public Offering (IPO) route. What does this mean for the dominance of the biotech IPO in Europe? In spite of the Covid-19 pandemic, biotech IPOs have continued unabated. In fact, a report from Bioworld found […]

August 13, 2020 - 7 minutesmins - By Jonathan Smith

In Depth 12 Aug 2020

Life at its Limits: The Biotech Industry Embraces Extremophiles

Sometimes in biotech, when your standard E. coli just won’t cut it, something more exotic is needed. Could extremophiles be the answer? Given enough time, and the right mutations, life can adapt to thrive in even the most inhospitable environments. From volcanic hot springs to hyper-saline soils, microbes have made their homes pretty much everywhere. […]

August 12, 2020 - 7 minutesmins - By Farhan Mitha

News and Trends 11 Aug 2020

How European Startups Have Advanced Cancer T-Cell Therapy in 2020

With the help of a huge €66M Series A round last week, the German startup T-knife is developing cancer T-cell immunotherapies with the help of genetically modified mice. However, this is just one of several cancer T-cell therapy startups making advances this year, with other innovations including off-the-shelf treatments and a potential universal cancer therapy. […]

August 11, 2020 - 8 minutesmins - By Kostas Vavitsas

Expert Advice 10 Aug 2020

Keep an Open Mind for a Successful Career in Biotech

It can pay to take your time and keep your options open when choosing a life sciences career. Henrijette Richter, Managing Partner at French VC Sofinnova Partners, knows this from her experience of becoming a successful biotech investor. Richter started out as a scientist working in the industry and completed a PhD with the Danish […]

August 10, 2020 - 13 minutesmins - By Helen Albert

News and Trends 6 Aug 2020

€112M Fund Launched to Commercialize UCL’s Gene Therapy Research

The leading UK institution University College London and the firm AlbionVC have made the first closing of a €112M (£100M) fund with the aim of investing in UCL research and spinouts with a focus on gene and cell therapy. This is the second so-called UCL Technology Fund and could double the size of the first, […]

August 6, 2020 - 2 minutesmins - By Antara Mazumdar

News and Trends 6 Aug 2020

DBV Technologies’ Peanut Allergy Patch Suffers FDA Setback

A request for market approval of a skin patch developed by French biotech DBV Technologies to treat peanut allergy has been turned down by the FDA, which has requested more data and design changes. The response from the FDA is a blow for the company which had been working towards getting the patch onto the […]

August 6, 2020 - 3 minutesmins - By Helen Albert

News and Trends 5 Aug 2020

Oxford Nanopore’s Portable Covid-19 Test Launched in UK

UK biotech Oxford Nanopore has launched a portable test that can detect both Covid-19 and seasonal flu viruses in saliva or swabs in a little over an hour. The quick output of Oxford Nanopore’s test, called LamPORE, is expected to be a huge improvement on existing polymerase chain reaction (PCR) tests, considered the gold standard […]

August 5, 2020 - 4 minutesmins - By Victor Kotsev

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Is Hepatitis D Healthcare Being Overlooked?

7 Biotech Books to Read in the Sun this Summer

Women’s Health Gains Traction as Bayer Pays €736M for UK Firm

CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO

Record Funding for Gene and Cell Therapy Accompanies Turbulent Times

Why are Some European Biotechs Going Public Without an IPO?

Life at its Limits: The Biotech Industry Embraces Extremophiles

How European Startups Have Advanced Cancer T-Cell Therapy in 2020

Keep an Open Mind for a Successful Career in Biotech

€112M Fund Launched to Commercialize UCL’s Gene Therapy Research

DBV Technologies’ Peanut Allergy Patch Suffers FDA Setback

Oxford Nanopore’s Portable Covid-19 Test Launched in UK

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!